JP2005539014A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005539014A5 JP2005539014A5 JP2004526380A JP2004526380A JP2005539014A5 JP 2005539014 A5 JP2005539014 A5 JP 2005539014A5 JP 2004526380 A JP2004526380 A JP 2004526380A JP 2004526380 A JP2004526380 A JP 2004526380A JP 2005539014 A5 JP2005539014 A5 JP 2005539014A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- alkyl
- carbon atoms
- heteroaromatic ring
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 38
- 125000004432 carbon atom Chemical group C* 0.000 claims 25
- 125000000217 alkyl group Chemical group 0.000 claims 18
- 125000001072 heteroaryl group Chemical group 0.000 claims 18
- 125000001931 aliphatic group Chemical group 0.000 claims 12
- 125000003118 aryl group Chemical group 0.000 claims 12
- -1 unsaturated acyclic hydrocarbon Chemical class 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- 239000004215 Carbon black (E152) Substances 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 6
- 125000005842 heteroatom Chemical group 0.000 claims 6
- 229930195733 hydrocarbon Natural products 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 229920006395 saturated elastomer Polymers 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 239000000651 prodrug Substances 0.000 claims 4
- 229940002612 prodrug Drugs 0.000 claims 4
- 230000004410 intraocular pressure Effects 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/212,437 US6864282B2 (en) | 2002-08-05 | 2002-08-05 | 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| PCT/US2003/024305 WO2004013119A1 (en) | 2002-08-05 | 2003-08-04 | The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005539014A JP2005539014A (ja) | 2005-12-22 |
| JP2005539014A5 true JP2005539014A5 (enExample) | 2006-09-28 |
Family
ID=31187772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004526380A Pending JP2005539014A (ja) | 2002-08-05 | 2003-08-04 | 高眼圧および緑内障処置用のプロスタグランジン類似体の９，１１−シクロエンドペルオキシドプロドラッグ |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6864282B2 (enExample) |
| EP (2) | EP1527063B1 (enExample) |
| JP (1) | JP2005539014A (enExample) |
| AT (1) | ATE334123T1 (enExample) |
| AU (1) | AU2003261352A1 (enExample) |
| CA (1) | CA2494146A1 (enExample) |
| DE (1) | DE60307106T2 (enExample) |
| ES (1) | ES2268433T3 (enExample) |
| WO (1) | WO2004013119A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7070768B2 (en) * | 2003-09-25 | 2006-07-04 | Allergan, Inc. | Method for imparting artificial tan to human skin |
| GB0501192D0 (en) * | 2005-01-20 | 2005-03-02 | Resolution Chemicals Ltd | Stable prostaglandin-containing compositions |
| WO2010102078A1 (en) | 2009-03-04 | 2010-09-10 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| US7851504B2 (en) * | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| EP1916002B1 (en) * | 2005-08-02 | 2014-03-05 | Santen Pharmaceutical Co., Ltd. | Method for prevention of degradation of thermally unstable substance |
| US7666912B2 (en) * | 2006-03-23 | 2010-02-23 | Massachusetts Eye And Ear Infirmary | Compositions and methods for reducing body fat |
| US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
| US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
| CA2866067C (en) | 2011-01-19 | 2015-04-21 | Topokine Therapeutics, Inc. | Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia |
| US8426471B1 (en) | 2011-12-19 | 2013-04-23 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
| WO2014081941A1 (en) | 2012-11-21 | 2014-05-30 | Topokine Therapeutics, Inc. | Methods and compositions for locally increasing body fat |
| NO2753788T3 (enExample) | 2013-05-10 | 2018-06-16 | ||
| US9820993B2 (en) | 2013-05-15 | 2017-11-21 | Topokine Therapeutics, Inc. | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat |
| US9115109B2 (en) | 2013-08-15 | 2015-08-25 | Chirogate International Inc. | Processes and intermediates for the preparations of isomer free prostaglandins |
| US10188661B2 (en) | 2014-06-27 | 2019-01-29 | Topokine Therapeutics, Inc. | Topical dosage regimen |
| ES2953032T3 (es) | 2017-09-01 | 2023-11-07 | Univ East Carolina | Métodos ex vivo para la activación de las células inmunológicas |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599353A (en) | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
| US4867915A (en) * | 1986-05-21 | 1989-09-19 | Syntex (U.S.A.) Inc. | 16-Substituted polyunsaturated hexadecanoic fatty acids |
| DE1300150T1 (de) | 1988-09-06 | 2003-09-18 | Pharmacia Ab, Stockholm | Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck |
| US5767154A (en) | 1991-02-07 | 1998-06-16 | Allergan | 5-trans-prostaglandins of the F series and their use as ocular hypotensives |
| US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5385945A (en) | 1992-10-21 | 1995-01-31 | Allergan, Inc. | 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds |
| US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
| ATE326972T1 (de) | 1997-10-13 | 2006-06-15 | R Tech Ueno Ltd | Heilende zusammensetzung für intraokulare hypertension oder glaukom |
| US6066671A (en) | 1997-12-19 | 2000-05-23 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides |
| DE60137335D1 (de) | 2000-08-07 | 2009-02-26 | Univ Vanderbilt | Nachweis der COX-2 Aktivität und von Anandamid-Metaboliten |
-
2002
- 2002-08-05 US US10/212,437 patent/US6864282B2/en not_active Expired - Fee Related
-
2003
- 2003-08-04 AT AT03767129T patent/ATE334123T1/de not_active IP Right Cessation
- 2003-08-04 JP JP2004526380A patent/JP2005539014A/ja active Pending
- 2003-08-04 AU AU2003261352A patent/AU2003261352A1/en not_active Abandoned
- 2003-08-04 EP EP03767129A patent/EP1527063B1/en not_active Expired - Lifetime
- 2003-08-04 DE DE60307106T patent/DE60307106T2/de not_active Expired - Fee Related
- 2003-08-04 WO PCT/US2003/024305 patent/WO2004013119A1/en not_active Ceased
- 2003-08-04 EP EP06011653A patent/EP1731516A3/en not_active Withdrawn
- 2003-08-04 ES ES03767129T patent/ES2268433T3/es not_active Expired - Lifetime
- 2003-08-04 CA CA002494146A patent/CA2494146A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005539014A5 (enExample) | ||
| CA2526534A1 (en) | Compounds and methods for delivery of prostacyclin analogs | |
| JPWO2020123827A5 (enExample) | ||
| JP2018524339A5 (enExample) | ||
| US8501793B2 (en) | Blood flow promoters for cauda equina tissues | |
| JP2010514786A5 (enExample) | ||
| JP2009523841A5 (enExample) | ||
| RU99103617A (ru) | Новые пара-терфенильные соединения | |
| JP2004530641A5 (enExample) | ||
| JP2012511023A5 (enExample) | ||
| JP2006528700A5 (enExample) | ||
| JP2003506491A5 (enExample) | ||
| JP2014505017A5 (enExample) | ||
| JPWO2021069705A5 (enExample) | ||
| JP2004507521A5 (enExample) | ||
| JP2008512408A5 (enExample) | ||
| JP2003107710A5 (enExample) | ||
| JPWO2020004649A5 (enExample) | ||
| RU2002122098A (ru) | Глазные гипотензивные липиды | |
| JP2002503714A5 (enExample) | ||
| JPH10287651A5 (enExample) | ||
| JP2003043690A5 (enExample) | ||
| JPWO2022228493A5 (enExample) | ||
| JP2002520286A5 (enExample) | ||
| JPH1077292A5 (enExample) |